Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Julphar
Daiichi Sankyo
Dow
QuintilesIMS
AstraZeneca
US Army
Merck
Harvard Business School

Generated: February 21, 2018

DrugPatentWatch Database Preview

Nisoldipine - Generic Drug Details

« Back to Dashboard

What are the generic sources for nisoldipine and what is the scope of nisoldipine freedom to operate?

Nisoldipine
is the generic ingredient in two branded drugs marketed by Mylan and Covis Pharma Bv, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for nisoldipine. Six suppliers are listed for this compound.
Pharmacology for nisoldipine
Medical Subject Heading (MeSH) Categories for nisoldipine

US Patents and Regulatory Information for nisoldipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan NISOLDIPINE nisoldipine TABLET, EXTENDED RELEASE;ORAL 091001-003 Jan 26, 2011 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NISOLDIPINE nisoldipine TABLET, EXTENDED RELEASE;ORAL 079051-001 Jul 25, 2008 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NISOLDIPINE nisoldipine TABLET, EXTENDED RELEASE;ORAL 091001-004 Jan 26, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NISOLDIPINE nisoldipine TABLET, EXTENDED RELEASE;ORAL 079051-003 Jul 25, 2008 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NISOLDIPINE nisoldipine TABLET, EXTENDED RELEASE;ORAL 091001-002 Jan 26, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NISOLDIPINE nisoldipine TABLET, EXTENDED RELEASE;ORAL 079051-002 Jul 25, 2008 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-007 Jan 2, 2008 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-001 Feb 2, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-005 Jan 2, 2008 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-002 Feb 2, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for nisoldipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-005 Jan 2, 2008 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-008 Jan 2, 2008 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-001 Feb 2, 1995 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-006 Jan 2, 2008 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-005 Jan 2, 2008 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-007 Jan 2, 2008 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-002 Feb 2, 1995 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-006 Jan 2, 2008 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-002 Feb 2, 1995 ➤ Sign Up ➤ Sign Up
Covis Pharma Bv SULAR nisoldipine TABLET, EXTENDED RELEASE;ORAL 020356-007 Jan 2, 2008 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Julphar
Express Scripts
Harvard Business School
Boehringer Ingelheim
Medtronic
Queensland Health
Citi
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot